Evidence map›Paper›PMID 12032844›Full record

ArticleOncogene2002

Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis.

Karin List, Christian C Haudenschild, Roman Szabo, WanJun Chen, Sharon M Wahl, William Swaim, Lars H Engelholm, Niels Behrendt, Thomas H Bugge

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01407471 (Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy), which is not on this map. Cited by 153 papers.

0numbers the graph read from it
0cells of the map it votes in
153citing papers in PubMed
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01407471 phase2completednot on this mapstarted 2011, after this paper: background citation

Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2011 to 2012Enrolled26ConditionsCutaneous Atrophy Due to CorticosteroidsArmsClobetasol + Spironolactone, Clobetasol + Placebo, Placebo + Spironolactone, Placebo + Placebo
3 · Its place in the literature

Who cites it

153 citing papers in PubMed, 333 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Hair follicles modulate skin barrier function.bioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. ENaC activation by proteases.Acta physiologica (Oxford, England) · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article

93 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Karin ListOral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, 30 Convent Drive, Bethesda, Maryland, MD 20892, USA.
Christian C Haudenschild
Roman Szabo
WanJun Chen
Sharon M Wahl
William Swaim
Lars H Engelholm
Niels Behrendt
Thomas H Bugge
National Institute of Dental and Craniofacial Research · USNational Institutes of Health · USAmerican Red Cross · US

Funding

Cell surface serine proteases in development, tissue repair, and malignancyZIADE000699 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI BUGGE, THOMAS H · 2009 to 2025
$34.1M
Normal And Pathologic Mechanisms Of Inflammation, Innate And Acquired ImmunityZIADE000046 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI WAHL, SHARON M · 2009 to 2012
$5.4M
Normal/Pathologic Mechanisms Of Inflammation &ImmunityZ01DE000046 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI WAHL, SHARON M · 1985 to 2008
$3.8M
Serine Proteases In Remodeling Of The Extracellular MatrZ01DE000699 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI BUGGE, THOMAS H · 2000 to 2008
$3.2M
6 · The paper itself

Abstract

Matriptase/MT-SP1 is a novel tumor-associated type II transmembrane serine protease that is highly expressed in the epidermis, thymic stroma, and other epithelia. A null mutation was introduced into the Matriptase/MT-SP1 gene of mice to determine the role of Matriptase/MT-SP1 in epidermal development and neoplasia. Matriptase/MT-SP1-deficient mice developed to term but uniformly died within 48 h of birth. All epidermal surfaces of newborn mice were grossly abnormal with a dry, red, shiny, and wrinkled appearance. Matriptase/MT-SP1-deficiency caused striking malformations of the stratum corneum, characterized by dysmorphic and pleomorphic corneocytes and the absence of vesicular bodies in transitional layer cells. This aberrant skin development seriously compromised both inward and outward epidermal barrier function, leading to the rapid and fatal dehydration of Matriptase/MT-SP1-deficient pups. Loss of Matriptase/MT-SP1 also seriously affected hair follicle development resulting in generalized follicular hypoplasia, absence of erupted vibrissae, lack of vibrissal hair canal formation, ingrown vibrissae, and wholesale abortion of vibrissal follicles. Furthermore, Matriptase/MT-SP1-deficiency resulted in dramatically increased thymocyte apoptosis, and depletion of thymocytes. This study demonstrates that Matriptase/MT-SP1 has pleiotropic functions in the development of the epidermis, hair follicles, and cellular immune system.

Indexed as

Amino Acid SequenceAnimalsAnimals, NewbornApoptosisBase SequenceEpidermisFemaleGene DeletionGenes, LethalHair FollicleHomeostasisMaleMembrane ProteinsMiceMice, KnockoutMicroscopy, Electron, ScanningmatriptaseMembrane ProteinsRNA, MessengerSerine EndopeptidasesSt14 protein, mouseTrypsin

Identifiers

PMID12032844
OpenAlexW1991757994

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.